James Harvey Knauss has years of experience in assisting companies with the regulatory maze associated with export and import of medical devices. He is listed with the FDA as a "United States Agent for Devices" as defined in Section 417 of the Modernization Act of 12997, for foreign companies that market medical devices in the United States.
Full Description:
To explain the variety and extent of James Harvey Knauss' expertise in regulatory and manufacturing systems, the following is a listing of some current and past activities:
Preparation and filing of Premarket Notifications [510(k)} and 513g's for medical devices.
Preparation and filing of Premarket Approval (PMA) applications.
Assistance in connection with misbranding and adulteration holds by the FDA.
Assistance with labeling, advertising issues and informed consent agreements. Assistance with drafting of protocols, informed consent forms, and related documents necessary for the filing of Investigative Device Exemption (IDE) applications.s
Assistance with FDA recalls or market withdrawals fo products.
Assistance during FDA GMP enspections. Drafting replies to FDA Form 483, listing of Addverse Finding and Warning letters.
Writing and production of medical device operators and service3 manuals that reduce product risk and satisfy FDA requirements.
Providing US Agent services for offshore manufacturers.